Middle East and Africa Genome Editing Market Segments and Growth by 2028

Middle East and Africa Genome Editing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (CRISPR, TALEN, Antisense, and Other), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028
  • Report Date : Mar 2022
  • Report Code : TIPRE00027824
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 127
Buy Now  
Middle East and Africa Genome Editing Market Segments and Growth by 2028
Report Date: Mar 2022   |   Report Code: TIPRE00027824
Buy Now
Page Updated: Mar 2022

The genome editing market in Middle East & Africa is expected to grow from US$ 205.01 million in 2021 to US$ 609.86 million by 2028; it is estimated to grow at a CAGR of 16.9% from 2021 to 2028.

Growing developments in the healthcare industry have led to increasing applications of biotechnology. Also, the growing support from governments, rising public-private partnerships, and increasing funding are widely enhancing the growth of the biotechnologies industry in the region. The value of the biotechnology industry is growing rapidly in the region due to the growing demand for biotechnology products to address changing diseases profile. In addition, the countries in the emerging regions serve vital growth opportunities due to the ever-increasing population and geriatric population. The heavy investments for the development of the healthcare sector have encouraged the adoption of advanced technologies. Moreover, the governments in the region offer tax incentives, cheaper land, incubators, and direct investment that have encouraged the local biotechnology companies to expand their abilities and capacities to contribute to improved healthcare services. Countries such as the UAE, Saudi Arabia, Oman, and Muscat are the most favorable destinations for the biotechnology industry. This is expected to increase the demand for genome editing and accelerate the market's growth in the coming years.Economic uncertainties and ongoing conflicts are worsening the condition in the region. For instance, countries such as Syria, Libya, and Yemen are suffering violent conflicts and cannot implement robust public health measures. Iran was in deep economic recession due to the US sanctions. Also, the major source of economic stabilization in Middle East countries is oil production and export. However, the recent pandemic is causing turbulence to the economies of the Middle East. A sudden drop in domestic and external demand for goods and products, especially crude oil, and halted production due to labor shortage, are major impacts observed in the region. The spread of COVID19 in the region caused heavy burdens on healthcare professionals. The government and the regulatory agencies are offering favorable support to the researchers and the market players to develop and explore genome based technologies treatment and immunization of the population in the region. These factors are projected to have progressive impact on the market in the Middle East & Africa region.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Middle East & Africa genome editing market. The Middle East & Africa genome editing market is expected to grow at a good CAGR during the forecast period.

Middle East & Africa Genome Editing Market Revenue and Forecast to 2028 (US$ Million)  

 

Middle East & Africa Genome Editing Market Revenue and Forecast to 2028 (US$ Million)  
  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Middle East & Africa Genome Editing Market Segmentation

Middle East & Africa Genome Editing Market – By Technology

  • CRISPR
  • TALEN
  • Antisense
  • Other

Middle East & Africa Genome Editing Market – By Application

  • Cell Line Engineering
  • Genetic Engineering
  • Diagnostic Applications
  • Drug Discovery
  • Others

Middle East & Africa Genome Editing Market – By End User

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Clinical Research Organizations (CRO's)

Middle East & Africa Genome Editing Market – By Country

  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

Middle East & Africa Genome Editing Market – Companies Mentioned

  • THERMO FISHER SCIENTIFIC INC.
  • MERCK KGaA
  • Lonza
  • Horizon Discovery Group plc.            
  • GenScript
  • New England Biolabs
  • Eurofins Scientific
  • CRISPR Therapeutics

Middle East and Africa Genome Editing Report Scope

Report Attribute Details
Market size in 2021 US$ 205.01 Million
Market Size by 2028 US$ 609.86 Million
CAGR (2021 - 2028) 16.9%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Technology
  • CRISPR
  • TALEN
  • Antisense
By Application
  • Cell Line Engineering
  • Genetic Engineering
  • Diagnostic Applications
  • Drug Discovery
By End User
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Clinical Research Organizations
Regions and Countries Covered Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • THERMO FISHER SCIENTIFIC INC.
  • MERCK KGaA
  • Lonza
  • Horizon Discovery Group plc.
  • GenScript
  • New England Biolabs
  • Eurofins Scientific
  • CRISPR Therapeutics
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Chat with us
DUNS Logo
87-673-9708
ISO Certified Logo
ISO 9001:2015
GDPR
CCPA